PRESS RELEASE published on 04/30/2024 at 18:00, 2 years 3 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.24. ABIVAX communique le nombre d'actions et de droits de vote au 31.03.24, conformément aux dispositions réglementaires. Abivax est une société de biotechnologie axée sur le développement de traitements thérapeutiques Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
BRIEF published on 04/05/2024 at 22:05, 2 years 4 months ago Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
BRIEF published on 04/05/2024 at 22:05, 2 years 4 months ago Abivax annonce la soumission de rapports financiers aux agences de régulation françaises et américaines Abivax Maladies Inflammatoires Chroniques Rapports Financiers Les Organismes De Réglementation Annonce De Diffusion Web
PRESS RELEASE published on 04/05/2024 at 22:00, 2 years 4 months ago Abivax a déposé ses rapports financiers auprès des autorités de marchés financiers française et américaine Abivax dépose ses rapports financiers auprès des autorités de marchés français et américaine, annonçant la disponibilité de ses documents pour l'année 2023 Biotechnologie Abivax Investisseurs Rapports Financiers Autorités De Marchés
PRESS RELEASE published on 04/05/2024 at 22:00, 2 years 4 months ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF published on 04/02/2024 at 08:35, 2 years 4 months ago Abivax Reports 2023 Financial Results and Operational Update Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
BRIEF published on 04/02/2024 at 08:35, 2 years 4 months ago Abivax publie ses résultats financiers 2023 et un point opérationnel Résultats Financiers Abivax Obefazimod Rectocolite Hémorragique Introduction En Bourse Au Nasdaq
PRESS RELEASE published on 04/02/2024 at 08:30, 2 years 4 months ago Abivax reports 2023 financial results and operational update Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024 Financial Results Fundraising Abivax Webcast Operational Update
PRESS RELEASE published on 04/02/2024 at 08:30, 2 years 4 months ago Abivax publie ses résultats annuels 2023 et présente un point d’avancement sur l’activité Abivax publie ses résultats annuels 2023 et présente un point d'avancement sur l'activité, démontrant une forte croissance financière et des progrès dans ses programmes cliniques Croissance Financement Abivax Résultats Annuels 2023 Programmes Cliniques
BRIEF published on 03/27/2024 at 18:05, 2 years 4 months ago ABIVAX publie son nombre d’actions et de droits de vote au 29 février 2024 Euronext Paris Droits De Vote Capital Social Abivax Réglementation
Published on 08/07/2026 at 00:45, 8 minutes ago NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 1 hour 38 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 2 hours 38 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 2 hours 48 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 2 hours 53 minutes ago Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/06/2026 at 22:15, 2 hours 38 minutes ago BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 3 hours 8 minutes ago FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 5 hours 48 minutes ago Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 6 hours 29 minutes ago EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026
Published on 08/06/2026 at 18:26, 6 hours 27 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 6 hours 27 minutes ago Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 7 hours 7 minutes ago Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 7 hours 8 minutes ago Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 7 hours 8 minutes ago Declaration of voting rights at the end of July 2026
